CAMBRIDGE, Mass.--(BUSINESS WIRE)--
Medicine, Inc. (NASDAQ:FMI) today announced that members of the
company's management team will present at the 2017 Wells Fargo
Healthcare Conference in Boston on Thursday, September 7, 2017, at 10:35
A live, listen-only webcast of the presentation may be accessed by
visiting the investors section of the company's website at investors.foundationmedicine.com.
A replay of the webcast will be available shortly after the conclusion
the presentation and will be archived on the company's website for 90
About Foundation Medicine
Foundation Medicine (NASDAQ:FMI)
is a molecular information company dedicated to a transformation in
cancer care in which treatment is informed by a deep understanding of
the genomic changes that contribute to each patient's unique cancer. The
company offers a full suite of comprehensive genomic profiling assays to
identify the molecular alterations in a patient's cancer and match them
with relevant targeted therapies, immunotherapies and clinical trials.
Foundation Medicine's molecular information platform aims to improve
day-to-day care for patients by serving the needs of clinicians,
academic researchers and drug developers to help advance the science of
molecular medicine in cancer. For more information, please visit http://www.FoundationMedicine.com
or follow Foundation Medicine on Twitter (@FoundationATCG).
Foundation Medicine® is a registered
trademark of Foundation Medicine, Inc.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170830005355/en/
Kimberly Brown, 617-418-2215
Source: Foundation Medicine, Inc.
News Provided by Acquire Media